Global Lyme Disease Diagnostic Devices Market Analysis 2015-2020
DUBLIN, Sept. 09, 2015 /PRNewswire/ --
Research and Markets (http://www.researchandmarkets.com/research/78bjqw/lyme_disease) has announced the addition of the "Lyme Disease Diagnostic Devices Market Analysis (2015 -2020)By Diagnostic Tests (Serological, Lymphocytic Transformation, PCR Analysis, Immunofluorescence Staining); By Technologies (Echocardiogram, MRI, Electrocardiogram, Flow Cytometry)" report to their offering.
Lyme disease caused by the spirochete Borrelia burgdorferi and transmitted by vector Ixodes scapular, is the most commonly reported vector-borne illness in the United States. Lyme disease incidence is increasing throughout the world.
Lyme disease diagnostic devices market has been segmented by diagnostic tests, diagnostic technologies and end users. Each of these segmentations has been further classified into sub segments to give an in-depth and comprehensive analysis of the Lyme disease diagnostic devices market.
Further the report provides geographic analysis of the Lyme disease and lists major companies involved in manufacturing of innovative diagnostic devices devices for the treatment of Lyme disease.
Key Topics Covered:
1. Lyme Disease diagnostic devices- Market Overview
2. Executive Summary
3. Lyme Disease diagnostic devices - Market Landscape
4. Lyme Disease diagnostic devices - Market Forces
5. Lyme Disease diagnostic devices - Strategic Analysis
6. Lyme Disease diagnostic devices market - By Diagnostic Tests
7. Lyme Disease diagnostic devices market- By Diagnostic Technologies
8. Lyme Disease diagnostic devices market - By End Users
9. Lyme Disease diagnostic devices market- By Geographic Analysis
10. Company Profiles
- Abbott Laboratories
- Canon U.SLife Sciences
- T2 Biosystems
- Bio-Rad Laboratories
- Alere Inc (ALR)
- Roche Diagnostics International Ltd.
- Graphene Frontiers
- Covance Inc.
- Boulder Diagnostics
- Immunetics Inc.
- GlaxoSmithKline Pharmaceuticals Ltd.
- Affymetrix Inc.
- Siemens AG
- Baxter International Inc.
- Fresenius Medical Care AG & Co.
For more information visit http://www.researchandmarkets.com/research/78bjqw/lyme_disease
Media Contact: Laura Wood , +353-1-481-1716, press@researchandmarkets.net
Share this article